NCT02945267 2016-10-26Nimotuzumab Plus S1 Versus Placebo Plus S1 as Maintenance Treatment in Patients With Unresectable Pancreatic CancerChinese PLA General HospitalPhase 4 Unknown60 enrolled
NCT02293356 2015-08-19Phase IV Clinical Trial of Nimotuzumab in the Treatment of Nasopharyngeal CarcinomaBiotech Pharmaceutical Co., Ltd.Phase 4 Unknown2,000 enrolled